Last 7 days
-0.1%
Last 30 days
3.3%
Last 90 days
-11.6%
Trailing 12 Months
-30.9%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-07-31 | van Houte Hans | sold | -12,020 | 9.6547 | -1,245 | chief financial officer |
2023-07-31 | Ring Christine | sold | -13,709 | 9.6547 | -1,420 | general counsel |
2023-07-31 | Hansen Gwenn | sold | -18,189 | 9.6547 | -1,884 | chief scientific officer |
2023-07-30 | Hansen Gwenn | acquired | - | - | 5,207 | chief scientific officer |
2023-07-30 | Ring Christine | acquired | - | - | 3,924 | general counsel |
2023-07-30 | van Houte Hans | acquired | - | - | 4,886 | chief financial officer |
2023-05-01 | Wolff Stefani | sold | -3,377 | 9.8763 | -342 | evp and coo |
2023-05-01 | Ring Christine | sold | -6,735 | 9.8763 | -682 | general counsel |
2023-05-01 | Hansen Gwenn | sold | -11,219 | 9.8763 | -1,136 | chief scientific officer |
2023-05-01 | van Houte Hans | sold | -7,120 | 9.8763 | -721 | chief financial officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | reduced | -4.37 | 48,000 | 690,000 | -% |
2023-09-06 | Deep Track Capital, LP | unchanged | - | 3,327,590 | 29,948,300 | 1.39% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 5.68 | 81,062 | 510,099 | -% |
2023-08-21 | Affinity Asset Advisors, LLC | reduced | -33.33 | -333,000 | 999,000 | 0.35% |
2023-08-16 | Nuveen Asset Management, LLC | reduced | -0.38 | 717,496 | 6,667,500 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | reduced | -40.33 | -1,578,250 | 3,223,250 | -% |
2023-08-15 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | reduced | -6.00 | 47,000 | 859,000 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | added | 19.69 | 102,872 | 399,730 | -% |
2023-08-15 | LAZARD ASSET MANAGEMENT LLC | added | 200 | 61,000 | 86,000 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | added | 234 | 891,041 | 1,213,380 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 24, 2023 | deep track capital, lp | 5.75% | 2,717,171 | SC 13G | |
Feb 14, 2023 | third rock ventures iii, l.p. | 0% | 0 | SC 13G/A | |
Feb 14, 2023 | deep track capital, lp | 4.81% | 2,266,569 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 6.9% | 3,253,736 | SC 13G/A | |
Feb 14, 2023 | redmile group, llc | 9.9% | 4,899,772 | SC 13G/A | |
Feb 14, 2023 | baker bros. advisors lp | 9.99% | 4,801,954 | SC 13G/A | |
Feb 08, 2023 | wasatch advisors inc | - | 0 | SC 13G | |
Jan 25, 2023 | blackrock inc. | 8.8% | 4,142,528 | SC 13G/A | |
Jun 10, 2022 | deep track capital, lp | 5.19% | 2,436,164 | SC 13G | |
Feb 14, 2022 | third rock ventures iii, l.p. | 5.4% | 2,422,549 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 07, 2023 | 8-K | Current Report | |
Aug 01, 2023 | 4 | Insider Trading | |
Aug 01, 2023 | 4 | Insider Trading | |
Aug 01, 2023 | 4 | Insider Trading | |
Jul 13, 2023 | 8-K | Current Report | |
Jul 13, 2023 | 10-Q | Quarterly Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AAPL | 2.7T | 383.9B | -3.49% | 14.63% | 28.86 | 7.12 | -0.93% | -4.89% |
MSFT | 2.4T | 211.9B | -3.06% | 31.92% | 32.56 | 11.12 | 6.88% | -0.52% |
GOOG | 1.7T | 289.5B | -1.47% | 30.51% | 27.19 | 5.72 | 4.10% | -15.36% |
AMZN | 1.3T | 538.0B | -4.72% | 10.07% | 101.87 | 2.47 | 10.73% | 12.62% |
MID-CAP | ||||||||
JBLU | 1.5B | 9.9B | -28.14% | -36.34% | 55.75 | 0.15 | 24.14% | 106.11% |
NYMT | 795.7M | 246.5M | -4.07% | -6.47% | -5.01 | 3.23 | 6.65% | -174.04% |
SMALL-CAP | ||||||||
TLRY | 1.6B | 627.1M | -7.75% | -14.29% | -1.08 | 2.51 | -0.20% | -204.67% |
PLAY | 1.5B | 2.2B | -10.06% | 7.70% | 11.01 | 0.71 | 38.20% | -10.10% |
MFA | 1.0B | 543.3M | -3.23% | 5.22% | -715.94 | 1.91 | 31.74% | 78.13% |
NKLA | 961.6M | 56.2M | -5.30% | -69.36% | -1.14 | 17.12 | 40.31% | -12.26% |
BYND | 614.9M | 356.8M | -16.65% | -37.31% | -2.19 | 1.72 | -23.03% | 15.53% |
GPRO | 507.0M | 1.0B | -15.90% | -35.94% | -19.18 | 0.49 | -11.34% | -107.10% |
CGC | 462.3M | 453.3M | 100.98% | -69.12% | -0.38 | 1.02 | -16.04% | 55.90% |
INO | 104.1M | 13.7M | -12.49% | -77.75% | -0.62 | 7.62 | 413.65% | 52.51% |
-33.9%
94.0%
91.0%
75.3%
Y-axis is the maximum loss one would have experienced if Nurix Therapeutics was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 46.2% | 60,935,000 | 41,691,000 | 38,627,000 | 39,240,000 | 38,701,000 | 34,360,000 | 29,750,000 | 29,043,000 | 22,876,000 | 19,967,000 | 17,820,000 | 12,993,000 | 19,488,000 | 24,745,000 | 31,115,000 | 39,004,000 | 37,346,000 | 36,936,000 |
Operating Expenses | 0.1% | 226,060,000 | 225,766,000 | 222,494,000 | 212,370,000 | 194,110,000 | 170,468,000 | 147,636,000 | 128,984,000 | 113,012,000 | 96,919,000 | 82,803,000 | 71,532,000 | 61,447,000 | 58,713,333 | 53,351,000 | 52,768,000 | - | - |
S&GA Expenses | 5.2% | 40,614,000 | 38,590,000 | 37,997,000 | 37,448,000 | 36,043,000 | 33,900,000 | 31,202,000 | 28,636,000 | 24,631,000 | 20,390,000 | 16,309,000 | 12,660,000 | 10,506,000 | 9,648,000 | 8,326,000 | 8,736,000 | - | - |
R&D Expenses | -0.9% | 185,446,000 | 187,176,000 | 184,497,000 | 174,922,000 | 158,067,000 | 136,568,000 | 116,434,000 | 100,348,000 | 88,381,000 | 76,529,000 | 66,494,000 | 58,872,000 | 50,941,000 | 49,065,333 | 45,025,000 | 44,032,000 | - | - |
EBITDA | - | - | - | -175,011,000 | -166,734,000 | -150,793,000 | -132,335,000 | -114,273,000 | -96,655,000 | -86,314,000 | -73,178,000 | -61,597,000 | -55,073,000 | -38,973,000 | -35,288,000 | -19,106,000 | -7,268,000 | - | - |
EBITDA Margin | - | - | - | -4.53 | -4.25 | -3.90 | -3.85 | -3.84 | -3.33 | -3.77 | -3.66 | -3.46 | -4.24 | -2.00 | -1.43 | -0.61 | -0.19 | - | - |
Earnings Before Taxes | - | - | - | -180,360,000 | -171,301,000 | -154,550,000 | -135,392,000 | -117,063,000 | -99,278,000 | -88,837,000 | -75,601,000 | -63,777,000 | -57,213,000 | -41,113,000 | -37,474,666 | -21,460,000 | -9,668,000 | - | - |
EBT Margin | - | - | - | -4.67 | -4.37 | -3.99 | -3.94 | -3.93 | -3.42 | -3.88 | -3.79 | -3.58 | -4.40 | -2.11 | -1.51 | -0.69 | -0.25 | - | - |
Net Income | 11.8% | -157,436,000 | -178,560,000 | -180,360,000 | -171,345,000 | -154,471,000 | -135,452,000 | -117,194,000 | -99,406,000 | -89,088,000 | -55,126,000 | -43,242,000 | -36,847,000 | -20,757,000 | -31,405,000 | -21,699,000 | -10,906,666 | -11,506,000 | -10,740,000 |
Net Income Margin | 100.0% | - | -4.28 | -4.67 | -4.37 | -3.99 | -3.94 | -3.94 | -3.42 | -3.89 | -2.76 | -2.43 | -2.84 | -1.07 | -1.27 | -0.70 | -0.28 | -0.31 | -0.29 |
Free Cashflow | 100.0% | - | -176,678,000 | -172,051,000 | -163,304,000 | -145,450,000 | -143,373,000 | -90,061,000 | -79,641,000 | -55,615,000 | -38,031,000 | -4,633,000 | 3,054,000 | 14,486,667 | 53,814,000 | -1,050,000 | 16,868,000 | - | - |
Balance Sheet | (In Millions) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2019Q4 |
Assets | -5.3% | 351 | 370 | 417 | 459 | 394 | 438 | 477 | 493 | 518 | 397 | 396 | 412 | 44.00 |
Current Assets | 0.6% | 290 | 288 | 318 | 355 | 307 | 280 | 311 | 358 | 396 | 311 | 298 | 364 | 39.00 |
Cash Equivalents | 75.6% | 59.00 | 34.00 | 64.00 | 48.00 | 42.00 | 79.00 | 81.00 | 147 | 188 | 126 | 119 | 266 | 35.00 |
Net PPE | 4.4% | 18.00 | 18.00 | 17.00 | 17.00 | 16.00 | 14.00 | 11.00 | 10.00 | 8.00 | 7.00 | 7.00 | 7.00 | 4.00 |
Liabilities | -5.6% | 91.00 | 96.00 | 113 | 117 | 128 | 132 | 134 | 118 | 120 | 127 | 106 | 104 | 54.00 |
Current Liabilities | 11.4% | 72.00 | 65.00 | 71.00 | 68.00 | 73.00 | 66.00 | 66.00 | 51.00 | 47.00 | 48.00 | 45.00 | 41.00 | 16.00 |
Shareholder's Equity | -5.2% | 260 | 274 | 304 | 343 | 267 | 306 | 342 | 375 | 398 | 270 | 290 | 308 | - |
Retained Earnings | -5.5% | -466 | -441 | -401 | -354 | -308 | -263 | -220 | -183 | -154 | -127 | -103 | -83.78 | -60.46 |
Additional Paid-In Capital | 1.2% | 728 | 719 | 709 | 701 | 579 | 571 | 564 | 558 | 552 | 398 | 394 | 391 | 3.00 |
Shares Outstanding | 0.4% | 48.00 | 47.00 | 47.00 | 47.00 | 45.00 | 45.00 | 45.00 | 44.00 | 44.00 | 39.00 | 39.00 | 8.00 | 3.00 |
Cashflow (Last 12 Months) | (In Millions) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 |
Cashflow From Operations | 8.7% | -151 | -165 | -159 | -152 | -136 | -135 | -84.36 | -73.94 | -50.10 | -33.00 | -0.08 | 8.00 | 18.00 | 56.00 | 1.00 | 18.00 |
Share Based Compensation | 6.4% | 32.00 | 31.00 | 28.00 | 25.00 | 22.00 | 19.00 | 16.00 | 13.00 | 10.00 | 7.00 | 4.00 | 2.00 | 1.00 | 1.00 | 1.00 | 0.00 |
Cashflow From Investing | 1502.2% | 52.00 | 3.00 | 27.00 | -64.33 | -13.49 | -65.83 | -108 | -196 | -292 | -237 | -254 | -134 | -34.83 | -47.58 | 8.00 | 17.00 |
Cashflow From Financing | -0.3% | 117 | 117 | 117 | 118 | 4.00 | 154 | 154 | 152 | 371 | 340 | 339 | 340 | 160 | 0.00 | 0.00 | 0.00 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
May 31, 2023 | May 31, 2022 | May 31, 2023 | May 31, 2022 | |
Total revenue | $ 30,676 | $ 11,432 | $ 43,361 | $ 21,053 |
Operating expenses: | ||||
Research and development | 45,763 | 47,493 | 91,579 | 90,630 |
General and administrative | 11,678 | 9,654 | 21,499 | 18,882 |
Total operating expenses | 57,441 | 57,147 | 113,078 | 109,512 |
Loss from operations | (26,765) | (45,715) | (69,717) | (88,459) |
Interest and other income, net | 2,488 | 314 | 4,707 | 525 |
Net loss | $ (24,277) | $ (45,401) | $ (65,010) | $ (87,934) |
Net loss per share, basic (in USD per share) | $ (0.45) | $ (1.01) | $ (1.20) | $ (1.96) |
Net loss per share, diluted (in USD per share) | $ (0.45) | $ (1.01) | $ (1.20) | $ (1.96) |
Weighted-average number of shares outstanding, basic (in shares) | 54,259,045 | 44,898,409 | 54,144,909 | 44,797,235 |
Weighted-average number of shares outstanding, diluted (in shares) | 54,259,045 | 44,898,409 | 54,144,909 | 44,797,235 |
Collaboration revenue | ||||
Total revenue | $ 10,676 | $ 11,432 | $ 23,361 | $ 21,053 |
License revenue | ||||
Total revenue | $ 20,000 | $ 0 | $ 20,000 | $ 0 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | May 31, 2023 | Nov. 30, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 58,958 | $ 64,474 |
Marketable securities, current | 222,219 | 244,667 |
Prepaid expenses and other current assets | 8,837 | 9,308 |
Total current assets | 290,014 | 318,449 |
Marketable securities, non‑current | 27,463 | 63,879 |
Operating lease right-of-use assets | 9,941 | 12,345 |
Property and equipment, net | 18,495 | 17,163 |
Restricted cash | 901 | 901 |
Other assets | 3,810 | 4,022 |
Total assets | 350,624 | 416,759 |
Current liabilities: | ||
Accounts payable | 4,525 | 5,064 |
Accrued expenses and other current liabilities | 18,091 | 22,428 |
Operating lease liabilities, current | 5,583 | 5,530 |
Deferred revenue, current | 44,063 | 37,633 |
Total current liabilities | 72,262 | 70,655 |
Operating lease liabilities, net of current portion | 3,758 | 6,434 |
Deferred revenue, net of current portion | 14,683 | 35,974 |
Total liabilities | 90,703 | 113,063 |
Commitments and contingencies (Note 6) | ||
Stockholdersʼ equity: | ||
Preferred stock, $0.001 par value— 10,000,000 shares authorized as of May 31, 2023 and November 30, 2022; no shares issued and outstanding as of May 31, 2023 and November 30, 2022 | 0 | 0 |
Common stock, $0.001 par value— 500,000,000 shares authorized as of May 31, 2023 and November 30, 2022; 47,631,208 and 47,172,299 shares issued and outstanding as of May 31, 2023 and November 30, 2022, respectively | 48 | 47 |
Additional paid-in capital | 728,038 | 709,220 |
Accumulated other comprehensive loss | (1,903) | (4,319) |
Accumulated deficit | (466,262) | (401,252) |
Total stockholdersʼ equity | 259,921 | 303,696 |
Total liabilities and stockholdersʼ equity | $ 350,624 | $ 416,759 |